When the World Health Organization’s Strategic Advisory Group of Experts on Immunisation considers, on October 6, evidence to decide on the roll out of the first malarial vaccine, the latest body of research – testing a vaccine combination with antimalarial drugs which demonstrated efficacy in preventing hospitalisations from severe malaria and deaths – is likely to bolster the case for …